Beclin-1, Bcl-2, and LC3-II were significantly downregulated, while LC3-I and p62 were significantly increased on the transcriptomic level in EMC patients compared to term controls (Figure 2B, panels a–e). This evidence concerns the gene BECN1 and extraskeletal myxoid chondrosarcoma.